Who founded Atomic Alchemy?

Atomic Alchemy was founded by Thomas Eiden in 2018.

Who are Atomic Alchemy's investors?

Atomic Alchemy's investors include Asymmetry Ventures, Breakwater Ventures, DCVC (Data Collective), Divergent Capital, Hemisphere Ventures LLC, SeaChange, Type One Ventures, Y Combinator and 2 more.

Who acquired Atomic Alchemy?

Atomic Alchemy was acquired by Oklo.

Where is Atomic Alchemy headquartered?

Atomic Alchemy is headquartered in Idaho Falls, US.

Atomic Alchemy

acquired by OkloYC W19

Idaho Falls, US · Founded 2018 · 8 employees · 10 known investors

Find your way into Atomic Alchemy

Paths you didn't know you had: your email and LinkedIn already hold routes to the Atomic Alchemy team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atomic Alchemy developed technology and facilities for producing radioisotopes for medical, industrial, and research applications, planning dedicated isotope-production reactors in Idaho. Acquired by Oklo in 2024.

Advanced Manufacturing Cleantech Climate Tech Deep Tech Energy Robotics Hard Tech Small Modular Reactors Medical DevicesUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W19)

Atomic Alchemy was founded in 2018 by Thomas Eiden.

Thomas Eiden FounderThomas Eiden worked as a reactor engineer and core designer at Idaho National Laboratory's Advanced Test Reactor and conducted research on next-generation nuclear fuels at the University of Wisconsin-Madison.

Investors · 10

Asymmetry Ventureslisted by Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred

How we know: Y Combinator's founder network · Not right? Tell us

Breakwater Ventureslisted by Breakwater VenturesSeattle

DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M

How we know: DCVC (Data Collective)'s portfolio page · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Divergent Capitallisted by Divergent CapitalNew York · $250K – $1M

How we know: Divergent Capital's portfolio page · Not right? Tell us

Hemisphere Ventures LLClisted by Hemisphere Ventures LLCMckinney

How we know: Hemisphere Ventures LLC's portfolio page · Y Combinator's founder network · Not right? Tell us

SeaChangelisted by SeaChange$250K – $1M

Type One Ventureslisted by Type One VenturesLos Angeles · $100K – $5M

How we know: Type One Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Thomas Jamesreported

How we know: Y Combinator's founder network · Not right? Tell us

Tuesday CapitalreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 4

OkloOklo develops next-generation fast fission reactors for producing clean electricity at scale, with a focus on safety features and the ability to use recycled nuclear waste as fuel. The company's Aurora reactor is designed to generate up to 75 megawatts of electrical power.

LuminateLuminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers. The company is advancing clinical-stage devices while supporting cancer patients, clinicians, and health systems.

Vena VitalsVena Vitals develops a noninvasive, continuous blood pressure monitoring device using patented sensor technology placed on the skin over an artery. The system targets anesthesiologists, sleep physicians, and hospitals for intraoperative, sleep disorder, and clinical monitoring applications.

NearWaveNearWave develops a handheld medical device using frequency domain near infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations for clinical and research applications. The device is positioned for use in clinical diagnostics, sports medicine, and cardiovascular health assessment.

Companies working in the same space as Atomic Alchemy.

Legal entities · 1

corporate structure

Atomic Alchemy Inc.

Frequently asked questions

What does Atomic Alchemy do?: Atomic Alchemy developed technology and facilities for producing radioisotopes for medical, industrial, and research applications, planning dedicated isotope-production reactors in Idaho. Acquired by Oklo in 2024.
Who founded Atomic Alchemy?: Atomic Alchemy was founded by Thomas Eiden in 2018.
Who are Atomic Alchemy's investors?: Atomic Alchemy's investors include Asymmetry Ventures, Breakwater Ventures, DCVC (Data Collective), Divergent Capital, Hemisphere Ventures LLC, SeaChange, Type One Ventures, Y Combinator and 2 more.
Who acquired Atomic Alchemy?: Atomic Alchemy was acquired by Oklo.
Where is Atomic Alchemy headquartered?: Atomic Alchemy is headquartered in Idaho Falls, US.